Aprea Therapeutics, Inc. · NASDAQ:APRE
Nantahala Capital Management, LLC's stake in Aprea Therapeutics, Inc. fell to 4.50% (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Nantahala Capital Management, LLC's stake in Aprea Therapeutics, Inc. fell to 4.50%, 411,520 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 4.50%
- Shares
- 411,520
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Nantahala Capital Management, LLC | 4.50% | 411,520 |
| Wilmot B. Harkey | 4.50% | 411,520 |
| Daniel Mack | 4.50% | 411,520 |
Source
Related
- Aprea Therapeutics, Inc.
- Nantahala Capital Management, LLC
- Aprea Therapeutics, Inc. shareholders
- Schedule 13G/A · Laurence W. Lytton · Aug 13, 2026
- Form 4 · Grissinger Michael · Jun 17, 2026
- Form 4 · Gruia Gabriela · Jun 17, 2026
- Form 4 · Peters Richard · Jun 17, 2026
- Form 4 · Henneman John B III · Jun 17, 2026